If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
748.00    -10.00 (-1.32%)
Bid:
747.50
Ask:
748.50
Spread: 1.00 (0.134%)
Market Cap: £2.52b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

2022 Performance Awards - EPS Condition

19 Apr 2022 12:00

RNS Number : 5995I
Drax Group PLC
19 April 2022
 

19 April 2022

Drax Group plc

("Drax" or the "Group"; Symbol:DRX)

 

2022 Performance Awards - EPS Condition

At the time of publishing the annual report for the financial year ended 31 December 2021, Drax advised it would be separately determining, and thereafter releasing details of, the Cumulative Adjusted Earnings per Share performance condition which applies to grants made to PDMRs and other employees in the 2022 financial year.

The vesting of awards granted are subject to satisfying two performance criteria over the financial years 2022, 2023 and 2024. 50% of the awards will be measured based on Relative Total Shareholder Return relative to the FTSE-350, and the remaining 50% will be measured based on Cumulative Adjusted Earnings per Share.

Following a meeting of the Remuneration Committee, the proposed Cumulative Adjusted EPS target for 2022 has been agreed. The EPS target was set after considering the company's internal forecasts, market expectations and sector peers.

 

 

Threshold

Target

Maximum

239.5p

266.1p

292.7p

 

 

BASIS OF VESTING

Performance

Target

% of Award Vesting(of EPS performance condition)

Below threshold

0%

Threshold

239.5p

25%

Maximum

292.7p

100%

 

Vesting between the threshold and maximum will be on a straight-line basis.

The EPS target is 'Adjusted EPS', derived from Adjusted Results as reported in the Company's audited financial statements. Instances where such adjustments might apply include acquisition and restructuring costs, asset obsolescence charges and certain remeasurements on derivative contracts.

There may arise circumstances during the performance period where adjustment or discretion is applied by the Remuneration Committee by reference to exceptional items and the Remuneration Policy. The application of such adjustments would be considered during and upon completion of the performance cycle. In making their assessment, the Remuneration Committee will take into account appropriate advice (for example from our auditors, Remuneration Committee advisers or the Audit Committee) and also give due consideration to the shareholder experience. The Remuneration Committee would also take into account exceptional and unforeseen circumstances, including wider considerations such as the prevailing market environment, in assessing the appropriate level of vesting judged against the performance of the Company and management at the end of the performance period.

Total Shareholder Return relative to the FTSE-350 will be measured over the three-year period (2022-2024) consistent with the approach previously approved by shareholders.

The Remuneration Committee of Drax considers that attaining outturn at the top end of the range would represent strong performance considering the uncertain economic circumstances and the challenges to the broader economy. 

 

Ends

 

Enquiries:

Drax Investor Relations: Mark Strafford

mark.strafford@drax.com 

+44 (0) 7730 763 949

Brett Gladden, Group Company Secretarybrett.gladden@drax.com+44 (0)7936 362586

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFEFSUEESEEL
Date   Source Headline
9th Jun 20237:30 amRNSTransaction in Own Shares
8th Jun 20237:30 amRNSTransaction in Own Shares
7th Jun 20234:22 pmRNSHolding(s) in Company
7th Jun 20239:54 amRNSHolding(s) in Company
7th Jun 20237:30 amRNSTransaction in Own Shares
6th Jun 202310:20 amRNSHolding(s) in Company
6th Jun 20237:30 amRNSTransaction in Own Shares
5th Jun 20237:30 amRNSTransaction in Own Shares
2nd Jun 202310:55 amRNSHolding(s) in Company
2nd Jun 202310:52 amRNSTotal Voting Rights
2nd Jun 20237:30 amRNSTransaction in Own Shares
1st Jun 20234:53 pmRNSDirector/PDMR Shareholding
1st Jun 20237:30 amRNSTransaction in Own Shares
31st May 20238:03 amRNSDrax response to Ofgem statement
31st May 20237:30 amRNSTransaction in Own Shares
30th May 20237:30 amRNSTransaction in Own Shares
26th May 20237:30 amRNSTransaction in Own Shares
25th May 20237:30 amRNSTransaction in Own Shares
25th May 20237:00 amRNSHolding(s) in Company
24th May 20237:30 amRNSTransaction in Own Shares
23rd May 20237:30 amRNSTransaction in Own Shares
23rd May 20237:00 amRNSCapital Markets Day - Update
22nd May 20237:30 amRNSTransaction in Own Shares
19th May 20237:30 amRNSTransaction in Own Shares
18th May 20237:00 amRNSShare Buyback Programme
16th May 202312:32 pmRNSNotice of Capital Markets Day
12th May 20237:00 amRNSDirector/PDMR Shareholding
11th May 20233:08 pmRNSNotice of Change to Director Details
27th Apr 20237:00 amRNSResult of AGM
26th Apr 20237:00 amRNSTrading Update and £150m Share Buyback Programme
20th Apr 202310:08 amRNSBlock listing Interim Review
20th Apr 202310:05 amRNSBlock listing Interim Review
20th Apr 202310:02 amRNSBlock listing Interim Review
17th Apr 202312:07 pmRNSDirector/PDMR Shareholding
14th Apr 20234:47 pmRNSDirector/PDMR Shareholding
4th Apr 202312:09 pmRNSDirector/PDMR Shareholding
4th Apr 20239:49 amRNSTotal Voting Rights
3rd Apr 20239:30 amRNSNotice of Change to Director Details
31st Mar 202312:55 pmRNSDirector/PDMR Shareholding
30th Mar 202310:35 amRNSFormal discussions with UK Gov on Power BECCS
17th Mar 20238:00 amRNSMailing of Annual Report and Notice of AGM
1st Mar 20234:49 pmRNSTotal Voting Rights
24th Feb 20239:30 amRNSDirector/PDMR Shareholding
23rd Feb 20237:00 amRNSAnnual Financial Report
22nd Feb 20237:42 amRNSCapacity Market Agreements
16th Feb 202311:02 amRNSNotice of Results
2nd Feb 20234:57 pmRNSTotal Voting Rights
13th Jan 20239:00 amRNSDrax Pumped Storage pays £6.12m for licence breach
4th Jan 202310:36 amRNSTotal Voting Rights
20th Dec 20226:13 pmRNSElectricity Generators Levy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.